{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By KATIE THOMAS", "person": [{"rank": 1, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Food and Drug Administration delays until 2017 decision on whether to require generic drug companies to assume more responsibility for warning patients on labels about product risks.", "type_of_material": "News", "word_count": "614", "lead_paragraph": "Consumer groups had urged the agency to close a loophole that keeps patients harmed by generic drugs from suing manufacturers.", "pub_date": "2016-05-20T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Delays Rule on Generic Drug Labels", "print_headline": "F.D.A. Delays Decision on Generic Drug Labels"}, "snippet": "Consumer groups had urged the agency to close a loophole that keeps patients harmed by generic drugs from suing manufacturers.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/05/20/business/fda-delays-rule-on-generic-drug-labels.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Labeling and Labels (Product)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Suits and Litigation (Civil)", "name": "subject"}], "blog": [], "_id": "573e4c6038f0d8366bbdfea8", "source": "The New York Times"}